跳至主要内容
临床试验/ACTRN12616001335482
ACTRN12616001335482已完成3 期

Comparing Co-Phenylcaine Forte Nasal Spray versus Co-Phenylcaine Forte Nasal Spray with Vanilla Liquid Flavour (L­132184) and Masking Liquid Flavour (50105AB) additives (CoPhenylcaine Zest): a phase III, randomised, double-­blind, crossover study.

Stuart Bailey0 个研究点目标入组 90 人开始时间: 2016年9月26日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 60 Years(—)
性别
All

入选标准

  • 1.Males or females aged between 18-60 years.
  • 2.Employees of Metro South Hospital and Health Service at Princess Alexandra Hospital.
  • 3.Available on two consecutive days from day of consent.
  • 4.Currently healthy and well.
  • 5.Able to read and complete Patient Information and Consent Form and questionnaire in English.

排除标准

  • 1. Pregnant or possibility of being pregnant.
  • 2. Previous hypersensitivity to local anaesthetics.
  • 3. Recent nasal surgery.
  • 4. Known nasal pathology, including sinusitis which affects daily living.
  • 5. History of cardiac disease.

研究者

发起方
Stuart Bailey

相似试验